Suchergebnisse - "2494G1JF75"

PubPharm (985)

71

Broadening the perspective when assessing evidence on boosted protease inhibitor-based regimens for initial antiretroviral therapy

enthalten in: Advances in therapy | 2010

von Hornberger, J. | Simpson, K. | Shewade, A. | +3

72

Prevalence, mutation patterns, and effects on protease inhibitor susceptibility of the L76V mutation in HIV-1 protease

enthalten in: Antimicrobial agents and chemotherapy | 2010

von Young, T. | Parkin, N. | Stawiski, E. | +4

73

A randomized factorial trial comparing 4 treatment regimens in treatment-naive HIV-infected persons with AIDS and/or a CD4 cell count <200 cells/μL in South Africa

enthalten in: The Journal of infectious diseases | 2010

von Phidisa II Writing Team for Project Phidisa | Ratsela, A. | Polis, M. | +56

CommentIn: J Infect Dis. 2010 Nov 15;202(10):1467-9. - PMID 20942649

74

In situ formation of nanoparticles upon dispersion of melt extrudate formulations in aqueous medium assessed by asymmetrical flow field-flow fractionation

enthalten in: Journal of pharmaceutical and biomedical analysis | 2010

von Kanzer, J. | Hupfeld, S. | Vasskog, T. | +5

75

HIV protease inhibitors elicit volume-sensitive Cl- current in cardiac myocytes via mitochondrial ROS

enthalten in: Journal of molecular and cellular cardiology | 2010

von Deng, W. | Baki, L. | Yin, J. | +2

76

Impact of hepatitis C and liver fibrosis on antiretroviral plasma drug concentrations in HIV-HCV co-infected patients : the HEPADOSE study

enthalten in: The Journal of antimicrobial chemotherapy | 2010

von Dominguez, S. | Ghosn, J. | Peytavin, G. | +7

77

Lopinavir/ritonavir monotherapy versus current treatment continuation for maintenance therapy of HIV-1 infection : the KALESOLO trial

enthalten in: The Journal of antimicrobial chemotherapy | 2010

von Meynard, J. | Bouteloup, V. | Landman, R. | +42

78

Antiretroviral release from poly(DL-lactide-co-glycolide) nanoparticles in mice

enthalten in: The Journal of antimicrobial chemotherapy | 2010

von Destache, C. | Belgum, T. | Goede, M. | +2

79

HIV-1 protease mutations and protease inhibitor cross-resistance

enthalten in: Antimicrobial agents and chemotherapy | 2010

von Rhee, S. | Taylor, J. | Fessel, W. | +8

80

Differential effects of efavirenz and lopinavir/ritonavir on human adipocyte differentiation, gene expression and release of adipokines and pro-inflammatory cytokines

enthalten in: Current HIV research | 2010

von Gallego-Escuredo, J. | Del Mar Gutierrez, M. | Diaz-Delfin, J. | +5